165 related articles for article (PubMed ID: 2119253)
21. Synergistic effect of the v-myc oncogene with H-ras on radioresistance.
McKenna WG; Weiss MC; Endlich B; Ling CC; Bakanauskas VJ; Kelsten ML; Muschel RJ
Cancer Res; 1990 Jan; 50(1):97-102. PubMed ID: 2403420
[TBL] [Abstract][Full Text] [Related]
22. II. Effect of n-3 and n-6 fatty acids on mammary H-ras expression and PGE2 levels in DMBA-treated rats.
Karmali RA; Chao CC; Basu A; Modak M
Anticancer Res; 1989; 9(4):1169-74. PubMed ID: 2510583
[TBL] [Abstract][Full Text] [Related]
23. EJ/ras neoplastic transformation of simian virus 40-immortalized human uroepithelial cells: a rare event.
Christian BJ; Kao CH; Wu SQ; Meisner LF; Reznikoff CA
Cancer Res; 1990 Aug; 50(15):4779-86. PubMed ID: 2164447
[TBL] [Abstract][Full Text] [Related]
24. No acquisition of metastatic capacity of R1H rhabdomyosarcoma upon transfection with c-Ha-ras oncogene.
Baisch H; Collard J; Zywietz F; Jung H
Invasion Metastasis; 1990; 10(4):193-207. PubMed ID: 2192992
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential.
Di Carlo E; Modesti A; Castrilli G; Landuzzi L; Allione A; de Giovanni C; Musso T; Musiani P
J Pathol; 1997 May; 182(1):76-85. PubMed ID: 9227345
[TBL] [Abstract][Full Text] [Related]
26. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
Oates AJ; Barraclough R; Rudland PS
Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
[TBL] [Abstract][Full Text] [Related]
27. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
28. Expression of Mts1, a metastasis-associated gene, increases motility but not invasion of a nonmetastatic mouse mammary adenocarcinoma cell line.
Ford HL; Salim MM; Chakravarty R; Aluiddin V; Zain SB
Oncogene; 1995 Nov; 11(10):2067-75. PubMed ID: 7478526
[TBL] [Abstract][Full Text] [Related]
29. Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations.
Waghorne C; Thomas M; Lagarde A; Kerbel RS; Breitman ML
Cancer Res; 1988 Nov; 48(21):6109-14. PubMed ID: 3167857
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of a novel gene, WDNM1, in nonmetastatic rat mammary adenocarcinoma cells.
Dear TN; Ramshaw IA; Kefford RF
Cancer Res; 1988 Sep; 48(18):5203-9. PubMed ID: 3136918
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel metastasis-suppressor region on human chromosome 12.
Luu HH; Zagaja GP; Dubauskas Z; Chen SL; Smith RC; Watabe K; Ichikawa Y; Ichikawa T; Davis EM; Le Beau MM; Rinker-Schaeffer CW
Cancer Res; 1998 Aug; 58(16):3561-5. PubMed ID: 9721861
[TBL] [Abstract][Full Text] [Related]
33. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
[TBL] [Abstract][Full Text] [Related]
34. Absence of Ras mutations in rat DMBA-induced mammary tumors.
Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs.
Mayr B; Dressler A; Reifinger M; Feil C
Am J Vet Res; 1998 Jan; 59(1):69-78. PubMed ID: 9442248
[TBL] [Abstract][Full Text] [Related]
36. Inheritance of a genetic factor from the Copenhagen rat and the suppression of chemically induced mammary adenocarcinogenesis.
Isaacs JT
Cancer Res; 1988 Apr; 48(8):2204-13. PubMed ID: 3127047
[TBL] [Abstract][Full Text] [Related]
37. Transfection of activated Ha-ras protooncogenes causes mouse mammary hyperplasia.
Miyamoto S; Guzman RC; Shiurba RA; Firestone GL; Nandi S
Cancer Res; 1990 Sep; 50(18):6010-4. PubMed ID: 2203525
[TBL] [Abstract][Full Text] [Related]
38. Generation of metastatic variants by transfection of a nonmetastatic rat mammary epithelial cell line with DNA from a metastatic rat mammary cell line.
Jamieson S; Barraclough R; Rudland PS
Pathobiology; 1990; 58(6):329-42. PubMed ID: 2078312
[TBL] [Abstract][Full Text] [Related]
39. Cytogenetic analysis of three rat liver epithelial cell lines (WBneo, WBHa-ras, and WBrasIIa) and correlation of an early chromosomal alteration with insulin-like growth factor II expression.
Sargent L; Dragan YP; Babcock K; Wiley J; Klaunig J; Pitot HC
Cancer Res; 1996 Jul; 56(13):2992-7. PubMed ID: 8674053
[TBL] [Abstract][Full Text] [Related]
40. [Integration of DNA oscillatory vector pSV neo to genome of NIH3T3: importance in investigations of transformation with c-Ha-ras oncogene].
Burzyński A; Wiśniewski R; Wojciechowski W; Porwit-Bóbr Z
Med Dosw Mikrobiol; 1994; 46(1-2):35-41. PubMed ID: 7967925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
